Landos Biopharma Ownership 2024 | Who Owns Landos Biopharma Now?

OverviewFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

9.89%

Retail Ownership

90.11%

Institutional Holders

1.00

Landos Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-12	-100.00%	-	Jun 30, 2024

Landos Biopharma's largest institutional shareholder is CORNERSTONE PLANNING GROUP LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-12	-100.00%	-	Jun 30, 2024

The largest Landos Biopharma shareholder by % of total assets is CORNERSTONE PLANNING GROUP LLC. The company owns 0.00 shares of Landos Biopharma (LABP), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-12	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Landos Biopharma's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -12.00 stocks of LABP, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-12	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Landos Biopharma's biggest institutional seller is CORNERSTONE PLANNING GROUP LLC. The company sold -12.00 shares of LABP, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-12	-100.00%	-	Jun 30, 2024

Landos Biopharma's largest sold out institutional shareholder by shares sold is CORNERSTONE PLANNING GROUP LLC, sold -12.00 shares, valued at -, as of undefined.

Landos Biopharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
DELAWARE GROUP EQUITY FUNDS IV	0.13%	147,182	-	-	Mar 28, 2024
BRIDGEWAY FUNDS INC	0.02%	39,000	-	-	Mar 28, 2024
DELAWARE GROUP EQUITY FUNDS IV	0.01%	14,718	-	-	Mar 28, 2024
JPMORGAN INSURANCE TRUST	0.00%	21,810	-	-	Mar 31, 2023
QUANTITATIVE MASTER SERIES LLC	0.00%	8,208	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.00%	617	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.00%	2,098	-	-	Mar 28, 2024
Voya INVESTORS TRUST	0.00%	36,027	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	88,220	-	-	Feb 29, 2024
SEASONS SERIES TRUST	0.00%	9,410	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	10,349	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	6,803	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	515	-	-	Mar 31, 2024
Goldman Sachs ETF Trust	0.00%	9,761	-	-	Feb 29, 2024
JPMorgan Trust I	0.00%	99,823	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	12,239	-34	-0.28%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	23,995	-	-	Mar 31, 2024
Global X Funds	0.00%	1,492	-	-	Jan 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	761	-	-	Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	1,200	-	-	Mar 31, 2024
NORTHERN FUNDS	0.00%	2,159	-	-	Mar 28, 2024
PROSHARES TRUST	0.00%	3,386	-	-	Feb 29, 2024
RYDEX SERIES FUNDS	0.00%	44	-	-	Dec 31, 2023
FIDELITY SALEM STREET TRUST	0.00%	34,798	-	-	Mar 31, 2024
ProFunds	0.00%	100	-	-	Mar 31, 2024
ALLSPRING MASTER TRUST	0.00%	538	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,763	-	-	Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	14,923	-	-	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	25	-	-	Dec 31, 2023
VALIC Co I	0.00%	1,735	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	2,399	-2,399	-50.00%	Mar 31, 2024
RYDEX VARIABLE TRUST	0.00%	6	-	-	Dec 31, 2023
Guggenheim Active Allocation Fund	0.00%	28	-	-	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	607	-	-	Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	611	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	4,000	4,000	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	200	-	-	Mar 31, 2023
COLLEGE RETIREMENT EQUITIES FUND	0.00%	3,166	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	746	-	-	Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	246	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	32,394	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	4,200	-	-	Mar 31, 2024
ETF Series Solutions	0.00%	32	-	-	Jan 31, 2024
TIAA-CREF FUNDS	0.00%	4,325	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	516	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,001	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	2,105	-	-	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	475	-	-	Dec 31, 2023
Guggenheim Active Allocation Fund	0.00%	2	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	639	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	763	-	-	Mar 31, 2024
Bridge Builder Trust	0.00%	720	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	935	-	-	Feb 29, 2024

Landos Biopharma's largest mutual fund holder by % of total assets is "DELAWARE GROUP EQUITY FUNDS IV", owning 147.18K shares, compromising 0.13% of its total assets.

Landos Biopharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	1	-
31 Dec, 23	1	-
31 Mar, 23	17	-15.00%
31 Dec, 22	20	-23.08%
30 Sep, 22	26	-18.75%
30 Jun, 22	32	-25.58%
31 Mar, 22	43	10.26%
31 Dec, 21	39	11.43%
30 Sep, 21	35	9.38%
30 Jun, 21	32	-31.91%
31 Mar, 21	47	4600.00%
31 Dec, 20	1	-

As of 31 Mar 24, 1 institutions are holding Landos Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	12	-
31 Dec, 23	12	-
31 Mar, 23	15,534,308	-1.34%
31 Dec, 22	15,744,848	-27.12%
30 Sep, 22	21,603,076	-3.84%
30 Jun, 22	22,466,549	-6.02%
31 Mar, 22	23,904,524	-4.19%
31 Dec, 21	24,949,116	10.03%
30 Sep, 21	22,674,777	-0.17%
30 Jun, 21	22,713,718	-2.32%
31 Mar, 21	23,253,704	23253604.00%
31 Dec, 20	100	-

Landos Biopharma (LABP) has 12.00 shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	0.00%	494550.00%
31 Dec, 23	0.00%	-
31 Mar, 23	2.40%	15.66%
31 Dec, 22	3.91%	13.58%
30 Sep, 22	5.37%	17.23%
30 Jun, 22	5.58%	15.83%
31 Mar, 22	5.94%	13.46%
31 Dec, 21	6.64%	20.63%
30 Sep, 21	5.67%	12.45%
30 Jun, 21	6.75%	8.49%
31 Mar, 21	8.92%	-
31 Dec, 20	-	-

As of 31 Mar 24, Landos Biopharma is held by 0.00% institutional shareholders, representing a 494550.00% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	-	-100.00%
31 Dec, 23	1	-
31 Mar, 23	7	-22.22%
31 Dec, 22	9	12.50%
30 Sep, 22	8	-42.86%
30 Jun, 22	14	-30.00%
31 Mar, 22	20	-9.09%
31 Dec, 21	22	46.67%
30 Sep, 21	15	36.36%
30 Jun, 21	11	-76.09%
31 Mar, 21	46	4500.00%
31 Dec, 20	1	-

- institutional shareholders have increased their position in LABP stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	-	-
31 Dec, 23	-	-
31 Mar, 23	6	20.00%
31 Dec, 22	5	-44.44%
30 Sep, 22	9	-30.77%
30 Jun, 22	13	8.33%
31 Mar, 22	12	71.43%
31 Dec, 21	7	-53.33%
30 Sep, 21	15	66.67%
30 Jun, 21	9	-
31 Mar, 21	-	-
31 Dec, 20	-	-

- institutional shareholders have reduced their position in LABP stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	1	-	12	-	0.00%	494550.00%	-	-100.00%	-	-
31 Dec, 23	1	-	12	-	0.00%	-	1	-	-	-
31 Mar, 23	17	-15.00%	15,534,308	-1.34%	2.40%	15.66%	7	-22.22%	6	20.00%
31 Dec, 22	20	-23.08%	15,744,848	-27.12%	3.91%	13.58%	9	12.50%	5	-44.44%
30 Sep, 22	26	-18.75%	21,603,076	-3.84%	5.37%	17.23%	8	-42.86%	9	-30.77%
30 Jun, 22	32	-25.58%	22,466,549	-6.02%	5.58%	15.83%	14	-30.00%	13	8.33%
31 Mar, 22	43	10.26%	23,904,524	-4.19%	5.94%	13.46%	20	-9.09%	12	71.43%
31 Dec, 21	39	11.43%	24,949,116	10.03%	6.64%	20.63%	22	46.67%	7	-53.33%
30 Sep, 21	35	9.38%	22,674,777	-0.17%	5.67%	12.45%	15	36.36%	15	66.67%
30 Jun, 21	32	-31.91%	22,713,718	-2.32%	6.75%	8.49%	11	-76.09%	9	-
31 Mar, 21	47	4600.00%	23,253,704	23253604.00%	8.92%	-	46	4500.00%	-	-
31 Dec, 20	1	-	100	-	-	-	1	-	-	-

Landos Biopharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 23, 2024	MAYLEBEN TIMOTHY M	director	-	D-Return	Sell	1,800	$7.90	$14.22K	-
May 23, 2024	MAYLEBEN TIMOTHY M	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Batycky Alka	director	-	D-Return	Sell	3,600	$3.05	$10.98K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	3,600	$14.70	$52.92K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	18,449	$3.70	$68.26K	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	48,813	-	-	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	39,999	$8.90	$355.99K	-
May 23, 2024	Oakes Gregory	director, officer	Chief Executive Officer	D-Return	Sell	54,454	-	-	-
May 23, 2024	Oakes Gregory	director, officer	Chief Executive Officer	D-Return	Sell	47,529	$3.70	$175.86K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 23, 2024	MAYLEBEN TIMOTHY M	director	-	D-Return	Sell	1,800	$7.90	$14.22K	-
May 23, 2024	MAYLEBEN TIMOTHY M	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Girao Tiago	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Callori Fred	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Batycky Alka	director	-	D-Return	Sell	3,600	$3.05	$10.98K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Adsett Roger	director	-	D-Return	Sell	3,600	$14.70	$52.92K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$3.30	$5.94K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$6.40	$11.52K	-
May 23, 2024	Garabedian Christopher Nishan	director	-	D-Return	Sell	1,800	$9.10	$16.38K	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	18,449	$3.70	$68.26K	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	48,813	-	-	-
May 23, 2024	Cataldi Fabio	officer	Chief Medical Officer	D-Return	Sell	39,999	$8.90	$355.99K	-
May 23, 2024	Oakes Gregory	director, officer	Chief Executive Officer	D-Return	Sell	54,454	-	-	-
May 23, 2024	Oakes Gregory	director, officer	Chief Executive Officer	D-Return	Sell	47,529	$3.70	$175.86K	-

The last insider sell of Landos Biopharma's stock was made by MAYLEBEN TIMOTHY M on May 23 2024, selling 1,800 shares at $7.90 per share (valued at $14.22K).

Landos Biopharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	21	-
Q1 2024	2	-	-
Q2 2023	6	-	-
Q1 2023	9	1	900.00%
Q4 2022	-	-	-
Q3 2022	2	1	200.00%
Q2 2022	12	1	1200.00%
Q1 2022	1	1	100.00%
Q4 2021	2	20	10.00%
Q3 2021	4	2	200.00%
Q2 2021	2	-	-
Q1 2021	22	8	275.00%

0 total buy trades, and 21 total sell trades (buy/sell ratio of 0.00%) were made by Landos Biopharma's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q2 2023	-	-	-
Q1 2023	4	1	400.00%
Q4 2022	-	-	-
Q3 2022	-	1	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	16	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	15	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Landos Biopharma's stocks.

Landos Biopharma Peer Ownership

Ticker	Company
ONCR	Oncorus, Inc.
XBIO	Xenetic Biosciences, Inc.
NEXI	NexImmune, Inc.
APLM	Apollomics, Inc.
RNAZ	TransCode Therapeutics, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.

LABP Ownership FAQ

Who Owns Landos Biopharma?

Landos Biopharma is owned by institutional shareholders (0.00%), insiders (9.89%), and public (90.11%). The largest institutional shareholder of Landos Biopharma is CORNERSTONE PLANNING GROUP LLC (0% of total shares) and the top mutual fund owner is DELAWARE GROUP EQUITY FUNDS IV (0.13% of total shares).

Who are the major institutional shareholders of Landos Biopharma?

Landos Biopharma's major institutional shareholders are CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Landos Biopharma shareholders are there?

As of Mar 2024, there are 1 institutional shareholders of Landos Biopharma.

What percentage of Landos Biopharma is owned by CORNERSTONE PLANNING GROUP LLC?

CORNERSTONE PLANNING GROUP LLC owns 0 shares of Landos Biopharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).